Search

everythinglearnresearchcommunity

for

Search:↓

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Dengue virus can infect human hair follicle cells and may cause hair loss.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Effective treatment significantly improves pododermatitis in dogs, reducing symptoms and extending remission.

PRP therapy might help increase hair growth for nonscarring alopecia, but more research is needed to confirm its effectiveness.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Glehnia littoralis and Andrographis paniculata extracts can significantly boost hair growth.

The formulated gel is a promising treatment for alopecia areata.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Alopecia areata treatment varies, with no optimal method established yet.